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Chemokines are small secreted proteins that regulate the migration of immune cells. The homeostatic chemokines are constitutively expressed in specific tissues or cells and regulate the migration of cells during development while inflammatory chemokines regulate leukocyte migration to the tissue during inflammation or during infectious disease (1) .
CCL2 is an inflammatory chemokine which can recruit macrophages (2, 3) , dendritic cells (4, 5) , bone marrow-derived cells (6) , and T cells (7, 8) to tissues. It has been shown to play an important role in development of neurodegenerative and neuroinflammatory brain diseases, such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis, and stroke (9) (10) (11) . CCL2 is constitutively expressed by resident cells in the central nervous system (CNS). In vitro studies showed CCL2 expression in neurons (12, 13) and astrocytes (12, 14) , and immunohistochemical studies confirmed its constitutive expression in glial cells and neuronal populations in different regions of the brain (15) . CCL2 was also detected in microglia sorted from CNS (16) . During inflammation, CCL2 is expressed by astrocytes (7, (17) (18) (19) (20) , microglia (17, 19, 21) , endothelial cells (7), infiltrating cells including lymphocytes (7) , and macrophages (7, 17) .
Studies have shown that direct injection of recombinant CCL2 to CNS induced leukocyte infiltration, mainly monocytes, and blood-brain barrier (BBB) breakdown (22, 23) . One of these studies implicated CCR2 as the receptor through which CCL2 acted (22) . Another study showed that injection of recombinant CCL2 to CNS induced a decrease in motor activity and behavioral changes, suggesting physiological role(s) for CCL2 in the CNS (24) .
Interpretation of experiments involving chemokine administration via injection is complicated by the fact that the accompanying tissue injury itself induces chemokines, including CCL2 (19, 20) . Transgenic expression using CNS-specific promoters has been used to obviate this problem. Interestingly, one of the transgenics described, using a myelin basic protein promoter, showed perivascular clinically silent leukocyte accumulation with rare parenchymal infiltration suggesting no BBB breakdown (3) . Another study showed that glial fibrillary acidic protein (GFAP) promoter-driven CCL2 induced milder disease and therefore resistance against experimental autoimmune encephalomyelitis (EAE) (25) , an experimental demyelinating disease that involves leukocyte infiltration and BBB breakdown (26) .
We have investigated the role of CCL2 at the interface between CNS and blood and its influence on inflammation. For this purpose, we induced CCL2 expression in CNS of naive CCL2-deficient mice, by intracisternal injection of non-replicating adenovirus encoding the murine CCL2 gene. Mice deficient for CCL2 have fewer monocytes in blood (27) predicting an increased T-cell/monocyte ratio.
We show that CCL2 gene delivery within the CNS induced leukocyte recruitment to CNS parenchyma without any other inflammatory or neuropathology.
Recruited leukocytes included macrophages and a high proportion of T cells, including regulatory and possibly Th1 CD4 T cells as well as CD8 T cells. We further show that this recruitment was not dependent on signaling through CCR2, a receptor for CCL2. The level of expression of CCR4, another receptor for CCL2, as well as CXCR3, a receptor for CXC-ligand chemokines such as CXCL10, which was also induced, were increased in the brain following intracisternal injection of adenovirus encoding CCL2. Neurons, astrocytes, and CD4 T cells can all express CCR4, and CD4 and CD8 T cells both expressed CXCR3. Our findings show a role for CCL2 in recruitment of lymphocytes in a CCR2-independent manner and indicate that redundancy among chemokine receptors including secondary chemokine circuits cooperate to ensure optimal T-cell recruitment.
MATERIALS AND METHODS

Mice
Female CCL2-deficient mice (28) and CCR2-red fluorescent protein (RFP)/RFP (29) mice were obtained from The Jackson Laboratory (Bar Harbor, ME, USA) and maintained in the Biomedical Laboratory, University of Southern Denmark (Odense). All experiments were approved by the Danish Animal Experiments Inspectorate (approval number 2014-15-0201-00369).
Intrathecal injection
CCL2-deficient or CCR2-RFP/RFP mice 8-10 weeks old were anesthetized with an intraperitoneal injection of ketamine (Ketalar Ò , 100 mg/kg of body weight; Pfizer, Glostrup, Denmark) and xylazine (Rompun Ò , 10 mg/kg of body weight; Bayer, Glostrup, Denmark). Eight microliters of replication-defective adenovirus [10 7 infectious units (ifu)] in sterile PBS was injected into the cisterna magna using a 30G stainless-steel needle curved (40°) at 2.5 mm from the tip (30) (31) (32) (33) . After the injection, mice received a subcutaneous injection of buprenorphine (Temgesic Ò , 0.1 mg/kg of body weight; Indivior UK Limited, Glostrup, Denmark). Adenovirus encoding CCL2 was type 5 E1-E3-deleted encoding the murine CCL2 gene (AdCCL2), driven by the CMV immediate-early promoter (34) , kindly provided by Prof J. Gauldie (Pathology & Molecular Medicine, McMaster University, Hamilton, ON, Canada). Adenovirus encoding the b-galactosidase gene (AdLacZ) was provided by Dr J. Nalbantoglu (Montreal Neurological Institute, Montreal, QC, Canada).
Seventeen days after injection, mice were anesthetized with pentobarbital (Mebumal Ò , 50 mg/kg of body weight; Glostrup, Denmark) perfused with ice-cold PBS and tissues were collected.
Flow cytometry and isolation of immune cells from CNS
Brains were chopped and forced through a 70 lm cell strainer (BD Biosciences, Søborg, Denmark). Myelin was removed from the brain cell suspension after a density gradient centrifugation (37% Percoll; GE Healthcare Biosciences AB, Søborg, Denmark). Cells were first incubated with a blocking solution containing anti-Fc receptor (Clone 2.4G; BD Pharmingen, Lyngby, Denmark) and Syrian hamster IgG (Jackson Immunoresearch Laboratories Inc., Skanderborg, Denmark) in PBS containing 2% fetal bovine serum (FBS, Sigma, Brøndby, Denmark) and 0.01% sodium azide and then with conjugated antibodies: anti-CD45 (30-F11; Biolegend, Copenhagen, Denmark), anti-TCRb (H57-597; Biolegend), anti-CD11b (m1/70; Biolegend), anti-CD4 (RM4-5; BD Biosciences, Lyngby, Denmark), anti-CD8 (53-6.7; Biolegend) in PBS containing 2% FBS and 0.01% sodium azide. Cells were acquired on a LSRII flow cytometer with FACSDiva software version 8.0 (BD Biosciences) and analyzed with FlowLogic (Inivai Technologies, Aarhus, Denmark) Version 6. Experiments were performed at least twice.
T cells were sorted on a FACSAria TM III cell sorter with FACSDiva software version 6. 
RNA extraction and quantitative PCR (qPCR)
RNA was extracted from brain homogenates using TRIzol reagent (Invitrogen Life Technologies, Naerum, Denmark) according to the manufacturer's instructions. RNA extractions from sorted cells were performed with the RNeasy Micro Kit (QIAGEN, Ballerup, Denmark). Reverse transcription was performed with M-MLV reverse transcriptase (Invitrogen, Naerum, Denmark) and random hexamers (TAG Copenhagen A/S, Frederiksberg, Denmark). Quantitative PCR was performed on an ABI Prism 7300 Sequence Detection System (Applied Biosystems, Naerum, Denmark) with Maxima TaqManÒ master mix kit (Applied Biosystems) was used for
Results were expressed relative to 18S rRNA (2 DCT formula) as endogenous control (TaqMan Ò Ribosomal RNA control Reagents kit; Applied Biosystems). cDNA was diluted for 18S rRNA analysis: 1/1000 for brain tissue and 1/200 for sorted cells.
Histology and immunofluorescence
Brains from PBS-perfused mice were fixed in paraformaldehyde 4% (PFA) for 1 h at 4°C then transferred to sucrose 30% overnight, embedded in cryostat embedding medium (Killik; Bio-Optica, Vedbaek, Denmark), and frozen in cold methylbutane. Frozen tissues were then cut into 12-lm thick cryostat sections.
For beta-galactosidase staining, brain sections were fixed in 1.5% glutaraldehyde in PBS (pH 7.4) for 5 min and then incubated overnight at room temperature in a solution of X-Gal (5-bromo-4-chloro-3-indolyl-b-galactopyranoside; Invitrogen; [0.4 mg/mL]) diluted in PBS (pH 7.4) containing magnesium chloride (10 mM), potassium ferricyanide (5 mM), and potassium ferrocyanide (5 mM). Sections were then counterstained with hematoxylin (Sigma). Images were acquired using an Olympus DP71 digital camera mounted on an Olympus BX51 microscope (Olympus, Ballerup, Denmark). For immunofluorescence staining, sections were washed in PBS and incubated for 30 min with 10% methanol, 10% H 2 O 2 in PBS to block endogenous peroxidase, or alternatively incubated for 10 min with ice-cold acetone. After repeated rinses with PBS containing 0.2% Triton 9100 (Merck, Hellerup, Denmark) (PBST), sections were incubated for 30 min in PBS containing 3% bovine serum albumin (BSA, Sigma) to block non-specific binding. Next, sections were incubated for 1 h at room temperature with corresponding primary antibodies: purified armenian hamster anti-CCR4 (2G12; Biolegend), PE rat anti-CD45 (30-F11; Biolegend), purified rat anti-CD4 (YTS 191.1.2) (35), purified rat anti-CD8 (YTS 169.4.2.1) (35), purified rabbit anti-laminin (polyclonal; Cedarlane, Skanderborg, Denmark), Cy3 mouse anti GFAP (G-A-5, Sigma), biotinylated mouse anti-NeuN (A60; Chemicon, Hellerup, Denmark), biotinylated rat anti-MOG (36) . The rat anti-CD4 and rat anti-CD8 were purified from hybridomas generously provided by Prof Steve Cobbold (University of Oxford, UK), and the anti-MOG was purified from the Z2 hybridoma kindly provided by Prof Christopher Linington (University of Glasgow, UK 
Statistical analysis
Results were analyzed using the two-tailed Mann-Whitney U-test using Prism 4 (GraphPad). p-values <0.05 were considered significant.
RESULTS
CCL2 expression in the CNS induces chemokine receptors
To investigate how CCL2 influences inflammation at the interface between the blood and brain parenchyma, we injected non-replicative adenovirus encoding murine CCL2 to the cerebrospinal fluid (CSF) via the cisterna magna of naive CCL2-deficient mice. Studies including our own had shown that adenoviral vectors injected by this route infected ependymal, choroidal, and leptomeningeal cells leading to transcription of the encoded gene and secretion of protein into the CSF and the CNS parenchyma (30-32, 37, 38) . We confirmed by RTqPCR that CCL2 was expressed in the brain (Fig. 1A) . Although a previous study showed adenovirus expression in spinal cord as well as brain (32) , in these experiments, CCL2 expression in the spinal cord was at the limit of detection and our analyses focused to the brain.
Viral vector-delivered CCL2 in mice deficient for this chemokine induced chemokine receptors. CCR2, the main receptor for CCL2, was increased (Fig. 1B) as well as CCR4 (Fig. 1B) , an alternative signaling receptor for CCL2 (39, 40) . CXCR3, a chemokine receptor not specific for CCL2, was also upregulated (Fig. 1B) .
CCL2 expression in the CNS induces the infiltration of cytokine-expressing cells in the brain
Chemokines play a role in recruitment of immune cells. We investigated by flow cytometry whether there were infiltrating cells in brains of CCL2-deficient mice infected with AdCCL2. A pronounced leukocyte infiltration was observed. It included a high proportion of lymphocytes (CD45 hi CD11b À ) (Fig. 1C,D (Fig. 1C) . These infiltrates were observed extra-and intraparenchymally in the brain (Fig. 1E ). CD4 and CD8 cells were localized in the cerebellum (Fig. 1F ), but also in the choroid plexus and meninges as well as in the brainstem (data not shown). Interestingly, this pronounced leukocyte infiltration did not cause demyelination (Fig. S1 ). Neither flow cytometry (Fig. 1C ) nor fluorescent microscopy ( Fig. 1E) showed cell infiltration in brains of CCL2-deficient mice that received a control adenovirus encoding b-galactosidase (AdLacZ) while, as expected, AdLacZ-infected cells were clearly visible in the brain (Fig. S2) .
We next investigated the expression of cytokines related to CD8 T cells and CD4 Th1 (IFNc), Th2 (IL-4), Th17 (IL-17A), pathogenic Th cells [granulocyte macrophage colony-stimulating factor (GM-CSF)] (41), and regulatory T cells (IL-10) in the brain. We observed an increase of IFNc and IL-10 ( Fig. 2A) . No changes were observed for IL-4 or GM-CSF ( Fig. 2A) , and IL-17A was not detected (data not shown). We also measured the level of CXCL10, a ligand for CXCR3, and observed an increase in mice infected with AdCCL2 ( Fig. 2A) . We next sorted CD4 T and CD8 T cells from brain of mice infected with AdCCL2 and measured expression of IFNc, IL-10, and FoxP3 by RT-qPCR. While both CD4 and CD8 T cells expressed IFNc (Fig. 2B) , only CD4 T cells expressed IL-10 and FoxP3 (Fig. 2B) . FoxP3 unequivocally identifies regulatory T cells (42) , which are known to express IL-10, whereas IFNc potentially can derive from a subset of regulatory T cells or from Th1 cells (43) . Thus, IFNc-expressing CD8 T, regulatory CD4 T, and/or Th1 cells were recruited by CCL2 expression in CNS.
These data suggest that CCL2 expression in the brain induced robust recruitment of T cells and that this was not sufficient to induce demyelination.
Lack of CCR2 does not affect T-cell infiltration
To address whether the recruitment of cells required CCR2 signaling, we injected AdCCL2 or AdLacZ to the cisterna magna of CCR2 RFP/RFP mice that lack functional CCR2 and investigated cells infiltrating the brain by flow cytometry. Notably, overexpression of CCL2 in the brains of mice lacking CCR2 (Fig. 3A) induced equivalent leukocyte infiltration (Fig. 3B-D) to that seen in CCR2-intact animals (Fig. 1C,D) . Both T cells and CD45 hi
CD11b
+ myeloid cells were also observed, but T cells were again the major leukocyte population recruited (Fig. 3C,D) . These results show that CCL2-induced recruitment of T cells can occur independently of CCR2.
The chemokine receptors CCR4 and CXCR3 were increased in brains of CCL2-deficient mice infected with AdCCL2. We determined the expression of these chemokine receptors in CD4 and CD8 T cells isolated from CCL2-deficient mice infected with AdCCL2. While both CD4 and CD8 T cells expressed CXCR3, only CD4 T cells expressed CCR4 (Fig. 4A) . We confirmed the expression of CCR2 promoter-driven RFP in lymphocytes by flow cytometry. Approximately 65% of CD4 T cells and 85% of CD8 T cells expressed RFP (Fig. 4B ). This shows that T cells express a range of chemokine receptors all of which could play a role in their recruitment to the brain. CCR2 has been shown to be expressed by neurons, microglia, and astrocytes in CNS (10). CCR4 expression was observed in neurons [NeuN + (Neuronal Nuclei)] in the brains of AdCCL2 and AdLacZ control-infected mice (Fig. S3) , and expression was induced by AdCCL2 in astrocytes (GFAP + ) (Fig. S3) .
DISCUSSION
We have shown that expression of the chemokine CCL2 in CNS of mice through intracisternal infection with AdCCL2 induced infiltration of T cells including regulatory CD4 T cells and IFNc-producing CD4 and CD8 T cells. Interestingly, these cells could be recruited in a CCR2-independent manner. We show that other chemokine receptors, including CCR4, also a receptor for CCL2, and CXCR3, a receptor for CXCL10, a chemokine that was also induced by AdCCL2, were expressed by T cells, and that CCR4 was expressed by neurons and astrocytes. CCL2 is predominantly implicated in recruitment of myeloid cells (2, 3, 6, 29, 44) . We observed a higher proportion of infiltrating lymphocytes than myeloid cells in our study. This supports our prediction of an increased T-cell/monocyte ratio in mice deficient for CCL2 which have fewer monocytes in blood (27) . Consistent with that, transgenic mice on a CCL2-intact background that overexpressed CCL2 in CNS under control of a myelin basic protein promoter showed a pronounced infiltration of mononuclear cells and few lymphocytes in the CNS (3). Mice given recombinant CCL2 by injection to CNS also showed monocyte infiltration (23) .
The fact that lymphocytes could still be detected in the CNS of AdCCL2-infected CCR2-deficient mice suggested that lymphocyte recruitment did not necessarily depend on CCR2. Consistent with this, we showed that using RT-qPCR, CCR4, another CCL2 receptor (39, 40) , was expressed by CD4 T cells, and CXCR3, a receptor for CXCL10, was expressed by CD8 and CD4 T cells. CCR4 has been reported to be expressed by different T-cell subtypes, but the predominant expression of this receptor was demonstrated on Th2 (45) (46) (47) , regulatory T (48, 49) , and Th17 (50, 51) cells. In our study, IL-17A transcripts were not detected, and no difference was observed in the level of IL-4 in AdCCL2-infected brain compared with controls. The increase of IL-10 in AdCCL2-infected brain together with the expression of IL-10, FoxP3, and CCR4 in CD4 but not in CD8 T cells isolated from brains overexpressing CCL2 allows suggestion, although speculative, of a role for the CCR4-CCL2 axis in recruitment of regulatory CD4 T cells. A recent study on head and neck squamous cell carcinoma supports this interpretation. In that study, CCR4 was predominantly expressed by activated regulatory T cells but not significantly expressed by CD8 T cells. Using a migration assay, it was shown that CCR4-CCL2 signaling was involved in trafficking of activated regulatory T cells (52) .
During inflammation, CXCL10 can be expressed by astrocytes (16, (53) (54) (55) , neurons (56, 57) , and microglia (16, 58, 59) . We showed that CXCL10 expression was increased in CNS of mice infected with AdCCL2. CXCR3 has been shown to be expressed by T cells, including Th1 cells (46, 47, 51, 60) , regulatory T cells (61) (62) (63) , and CD8 T cells (53, 55, 56) . In our study, CD8 T cells were detected in the CNS of mice lacking CCR2. These cells, like a number of the CD4 cells, expressed CXCR3. It is possible that CCL2 did not act directly on CD8 T cells, or on those CD4 cells that lacked a CCL2 receptor, but acted indirectly via a chemokine cascade that involved production of CXCL10 which signaled through the CXCR3 receptor.
It has been shown that chemokines can induce neurotransmitter release by neurons or astrocytes, and neurotransmitters can also induce chemokine secretion (10) . Studies reported that CCL2 could enhance a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and N-methyl-D-aspartate (NMDA) receptor currents (64) , and induce thermal hyperalgesia by sensitizing NMDA and AMPA receptors (65) . In vitro studies showed that CCL2 could be induced by neurotransmitters (66, 67) . Several chemokine receptors, including CCR2, have been reported expressed by glial cells and neurons (10, 68) . CCR4 has been so far reported only in neurons or astrocytes in culture (69) (70) (71) . We found that astrocytes and neurons expressed CCR4 in vivo. Whether CCR4-expressing CNS-resident cells play a role in chemokine cascades was not examined. It seems reasonable to speculate that CCL2 could activate astrocytes or neurons to secrete neurotransmitters and/or chemokines via neurotransmitter intermediates. CD45 hi CD11b + myeloid cells could also be detected in the CNS of AdCCL2-infected CCR2-deficient mice. The proportion of recruited myeloid cells in brains of CCR2 RFP/RFP mice was not significantly different from that observed in CCR2-intact animals. Mice deficient for CCR2 similar to CCL2-deficient mice also have fewer monocytes in blood (72) , which could explain the lack of difference in proportions of CD45 
CD11b
+ myeloid cells in AdCCL2-infected CCR2-deficient mice were not investigated, but CCR4 is one possibility (73) .
We have induced recruitment of T lymphocytes to the CNS via viral vector-driven expression of CCL2. Absence of accompanying pathology emphasizes that recruitment alone is not sufficient for neuroinflammation but that other signals are required (41) . The fact that this recruitment, as well as of myeloid cells, was equivalent in mice lacking functional CCR2 means that CCL2 can act through (an)other receptor(s). We have shown that CD4 T cells express the alternative CCL2-signaling receptor, CCR4, allowing the possibility that CD4 T cells were recruited to the CNS via CCR4. Many of the recruited cells, especially CD8 T cells, expressed CXCR3 and did not express CCR4, pointing to a role for CXCR3-binding chemokines such as CXCL10, and a CCL2-induced chemokine cascade. These results add support to chemokines as major inducers of infiltration to the CNS and show that redundancy in receptor signaling optimizes these responses.
SUPPORTING INFORMATION
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